Prevalence and determinants of sarcopenia risk among older people: evidence from a cross-sectional study
Open Access
- 2 February 2026
- journal article
- Published by JURUFRA SL in Retos
- Vol. 75, 306-318
Abstract
Background/Objectives: Sarcopenia is associated with multiple negative consequences. This study aims to explore the prevalence of sarcopenia risk and its possible associated factors among older adults in Hungary. Methods: A total of 310 older adults were included in this cross-sectional study. The study protocol was registered on clinicaltrials.gov under the identifier NCT05313360 on 28 March 2022. The participants filled a questionnaire that included demographics, medical history, nutritional status, physical activity level, health-related quality of life, and general health status. SARC-F questionnaire was used to screen for sarcopenia risk among the study participants. Results: Our results showed that the prevalence of sarcopenia risk was 26.8%. The predictors in the univariate regression model included age (p < .001), number of medications (p < .001), number of diseases (p < .001), number of outpatient physician visits(p = .001), MNA-SF score (p < .001), and GPAQ score (p < .001). After controlling for age in Block 1 (R² = .295), our multivariate linear hierarchical regression model (Block 2, R² = .483) demonstrated that the number of medications (p = .013), number of diseases (p = .007), MNA-SF score (p < .001), and total GPAQ score (p = .004) significantly were significant independent predictors of a greater sarcopenia risk. Conclusion: the number of medications, the number of diseases, MNA-SF, and total GPAQ scores significantly predicted sarcopenia risk. Further longitudinal studies are recommended to examine the development of sarcopenia over timewith.Keywords
This publication has 52 references indexed in Scilit:
- Prevalence of and risk factors for sarcopenia in community‐dwelling people: The Vietnam Osteoporosis StudyJournal of Cachexia, Sarcopenia and Muscle, 2023
- Assessing quality of life with SarQol is useful in screening for sarcopenia and sarcopenic obesity in older womenAging Clinical and Experimental Research, 2023
- Sarcopenia and health‐related quality of life: A systematic review and meta‐analysisJournal of Cachexia, Sarcopenia and Muscle, 2023
- Sarcopenia and polypharmacy among older adults: A scoping review of the literatureArchives of Gerontology and Geriatrics, 2022
- Global prevalence of sarcopenia and severe sarcopenia: a systematic review and meta‐analysisJournal of Cachexia, Sarcopenia and Muscle, 2021
- Cellular and molecular mechanisms of sarcopenia: the S100B perspectiveJournal of Cachexia, Sarcopenia and Muscle, 2018
- Quality of life in sarcopenia measured with the SarQoL®: impact of the use of different diagnosis definitionsAging Clinical and Experimental Research, 2017
- Potentially inappropriate medication related to weakness in older acute medical patientsInternational Journal of Clinical Pharmacy, 2014
- SARC-F: A Simple Questionnaire to Rapidly Diagnose SarcopeniaJournal of the American Medical Directors Association, 2013
- Adverse Drug Events in Older Geriatric PatientsDrug Safety, 2012